US Patent 8163287 Combination therapy of her expressing tumors

Patent 8163287 was granted and assigned to Genentech on April, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

81632870

Patent Inventor Names

Mark X. Sliwkowski0

Stephen M. Kelsey0

Date of Patent

April 24, 2012

Patent Application Number

114904380

Date Filed

July 19, 2006

Patent Citations Received

‌

US Patent 11992529 Adjuvant treatment of HER2-positive breast cancer

‌

US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer

‌

US Patent 12110341 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof

Patent Primary Examiner

‌

Alana Harris Dent

Patent abstract

The invention relates to tumors expressing HER2 and EGFR, using HER2-dimerization inhibitors (HDIs) and EGFR inhibitors.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8163287 Combination therapy of her expressing tumors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API